Skip to main content
Premium Trial:

Request an Annual Quote

Maravai LifeSciences Acquires Glen Research

NEW YORK (GenomeWeb) – Maravai LifeSciences announced today that it has acquired Glen Research, a Virginia-based provider of DNA and RNA synthesis reagents.

Specific terms of the deal were not disclosed.

"The acquisition supports our commitment to the genomics market, which we first entered with the acquisition of TriLink BioTechnologies," Maravai President Eric Tardif said in a statement. Maravai acquired TriLink in 2016.

Maravai was launched in 2014 by private equity firm GTCR in partnership with Tardif and Carl Hull, two former Gen-Probe executives. In addition to TriLink, the company also recently acquired analytical product supplier Cygnus Technologies and made a strategic equity investment in life science tools firm Vector Laboratories.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.